Do you need a District of Columbia Procrit attorney? Contact one of our District of Columbia Procrit attorneys now.
Home : Unsafe Drugs : Procrit : News Articles
Procrit - News Articles
-
Jul 8, 2008
The Star-Ledger - NJ.com, NJ -
by Jeff May/The Star-Ledger With sales of key products flagging, the biggest hits are from Schering-Plough, which plans to cut more than 500 jobs statewide, ... -
Jul 8, 2008
The Star-Ledger - NJ.com, NJ -
BY JEFF MAY With sales flagging and cost-cutting at a premium, pharmaceutical companies have notified New Jersey of plans to trim or relocate more than 800 jobs in the coming months. The biggest hit is from Schering-Plough, which plans to cut ... -
Jul 9, 2008
FiercePharma, DC -
By Christe Bruderlin-Nelson Schering-Plough will cut a minimum of 500 jobs starting on August 11 th in New Jersey as part of a much larger plan to layoff 5,500 employees across the globe . At the same time, Johnson & Johnson will send about the same ... -
Jul 8, 2008
Newsday, NY -
TRENTON, NJ - More than 1100 pharmaceutical workers in New Jersey will be losing their jobs starting in August. Most of the job cuts are part of major previously announced restructurings at Johnson & Johnson and Schering-Plough Corp. This week, the companies specified how many ... -
Jul 8, 2008
CNNMoney.com -
NEW YORK (Associated Press) - More than 800 pharmaceutical jobs will be leaving New Jersey starting in August. Most of the job cuts and transfers are part of major previously announced restructurings at Johnson & Johnson and Schering-Plough Corp. This week, the companies specified how many ... -
Jul 8, 2008
Bizjournals.com, NC -
Johnson & Johnson said Tuesday it is moving about 260 positions from its Ortho Biotech unit to Centocor in Horsham, Pa. The New Brunswick, NJ, ... -
Jul 17, 2008
Zacks.com, IL -
The safety issues surrounding erythropoietin stimulating agents have also negatively affected sales of anemia drug Procrit. While the company has a number of late-stage candidates that are expected to be commercialized in the near-term, they will not begin to make a ... -
Jul 18, 2008
exchange4media.com, India -
Johnson & Johnson has kicked off a soup-to-nuts review for its $25 billion pharmaceuticals group. Marc Monseau, Director-Public Affairs at Johnson & Johnson ... -
Jul 15, 2008
Business Spectator, Australia -
By Ransdell Pierson of Reuters NEW YORK -- Johnson & Johnson posted second-quarter earnings that beat Wall Street expectations, as strong demand for its medical devices and consumer products overshadowed negligible growth of prescription drugs. The diversified health-care company said ... -
Jul 15, 2008
Kansas City Star, MO -
By LINDA A. JOHNSON AP Business Writer Health-care giant Johnson & Johnson said Tuesday its second-quarter profit rose 8 percent and beat forecasts on ...
-
Jul 15, 2008
Ottawa Citizen, Canada -
NEW YORK - Johnson & Johnson posted second-quarter earnings that beat Wall Street expectations yesterday, as strong demand for its medical devices and consumer products overshadowed negligible growth of prescription drugs. The diversified health care company said it earned $3.3 billion, ... -
Jul 14, 2008
Pacific Coast Business Times, CA -
Shares of Thousand Oaks-based Amgen rose $0.88 on July 14 after the company announced it will pay $200 million to settle a patent infringement claim. ... -
Jul 14, 2008
Wall Street Journal Blogs, NY -
Amgen Inc. agreed to pay $200 million to settle an antitrust lawsuit by Johnson & Johnson's Ortho Biotech Products unit, putting to rest 2½ years of legal ... -
Jul 14, 2008
Wall Street Journal Blogs, NY -
Amgen and Johnson & Johnson have come to a truce a two-and-a-half year battle over marketing of rival oncology products. Amgen has agreed to pay $200 million to settle an antitrust lawsuit by Johnson & Johnson over discounts and incentives that Amgen offered to cancer ... -
Jul 18, 2008
Adweek, NY -
The group includes Procrit, Topomax and Ultram, and estimated annual marketing support likely tops $100 million. Agency assignments could not be immediately determined, nor could a timeline for the process. ... -
Jun 11, 2008
Medscape (subscription) -
Manufactured by Amgen, the products are marketed under 2 different brand names: Epogen and Procrit. Amgen distributes Epogen, and Ortho Biotech, ... -
May 30, 2008
PR Newswire (press release), NY -
About PROCRIT(R) (Epoetin alfa) PROCRIT is used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal ... -
Jun 1, 2008
Medical News Today (press release), UK -
PROCRIT is used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal failure who are on dialysis and those who are not on dialysis, who are being treated with zidovudine for HIV infection, and to reduce the ... -
Jun 3, 2008
GenomeWeb News (subscription), NY -
By Kirell Lakhman CHICAGO (GenomeWeb News) — An increasing body of evidence is showing that erythropoietin, the widely used hematopoietic drug used to ... -
Jun 3, 2008
Newsinferno.com, NY -
Some cancer patients treated with the anemia drugs Procrit, Aranesp and Epogen could experience increased tumor growth. However, researcher recently ...
Do you need a District of Columbia Procrit attorney? Contact one of our District of Columbia Procrit attorneys now.
Pages: 1 2 3 4 5 6 ... Next
These articles are related to: Procrit, Procrit Claim, Procrit Lawsuit, Procrit Law Suit, Procrit Law Firm, Procrit Lawyer, Procrit Attorney, Procrit Trial, Procrit Verdict, Procrit News, Procrit Information, Procrit Lawyers, Procrit Litigation, Procrit Case, Procrit Side Effects, Procrit Recall, Procrit Warning, Procrit Class Action, Aranesp, Chemotherapy, Anemia, Kidney Transplant
